Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.

Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile

Open access
Rea, Mary C., Sit, Clarissa S., Clayton, Evelyn, O'Connor, Paula M., Whittal, Randy M., Zheng, Jing, Vederas, John C., Ross, R. Paul, Hill, Colin · 2010 · Proceedings of the National Academy of Sciences

Abstract

The last decade has seen numerous outbreaks of Clostridium difficile-associated disease (CDAD), which presented significant challenges for healthcare facilities worldwide. We have identified and purified thuricin CD, a two-component antimicrobial that shows activity against C. difficile in the nanomolar range. Thuricin CD is produced by Bacillus thuringiensis DPC 6431, a bacterial strain isolated from a human fecal sample, and it consists of two distinct peptides, Trn-alpha and Trn-beta, that act synergistically to kill a wide range of clinical C. difficile isolates, including ribotypes commonly associated with CDAD (e.g., ribotype 027). However, this bacteriocin thuricin CD has little impact on most other genera, including many gastrointestinal commensals. Complete amino acid sequencing using infusion tandem mass spectrometry indicated that each peptide is posttranslationally modified at its respective 21st, 25th, and 28th residues. Solution NMR studies on [(13)C,(15)N] Trn-alpha and [(13)C,(15)N]Trn-beta were used to characterize these modifications. Analysis of multidimensional NOESY data shows that specific cysteines are linked to the alpha-carbons of the modified residues, forming three sulfur to alpha-carbon bridges. Complete sequencing of the thuricin CD gene cluster revealed genes capable of encoding two S'-adenosylmethionine proteins that are characteristically associated with unusual posttranslational modifications. Thuricin CD is a two-component antimicrobial peptide system with sulfur to alpha-carbon linkages, and it may have potential as a targeted therapy in the treatment of CDAD while also reducing collateral impact on the commensal flora.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0913554107

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Research works printed but not linked: 4

  1. ; Center for Infections Mandatory Surveillance Team Health Protection Agency Summary points and commentary on quarterly calendar year and financial year Clostridium difficile data derived from Mandatory Surveillance. January 2009. Available at http://www.hpa.org.uk/webw/HPAweb&HPAwebStandard/HPAweb_C/1195733750761?p=1179745282408. Accessed April 8 2010. (2009).
  2. 10.1016/j.fmrre.2004.12.005 · doi:10.1016/j.fmrre.2004.12.005 · Paper page
  3. 10.1111/j.1574-6976.2001.tb00579.x · doi:10.1111/j.1574-6976.2001.tb00579.x · Paper page
  4. 10.1111/j.1574-6976.1998.tb00358.x · doi:10.1111/j.1574-6976.1998.tb00358.x · Paper page

Cited by

See all 617

Metadata

Authors
Rea, M. C., Sit, C. S., Clayton, E., O'Connor, P. M., Whittal, R. M., Zheng, J., Vederas, J. C., Ross, R. P., & Hill, C.
Affiliations
  • Teagasc - The Irish Agriculture and Food Development Authority (IE)
  • University of Alberta (CA)
  • Biotechnology Department, Teagasc, Moorepark Food Research Centre, Fermoy, Ireland;
  • University College Cork (IE)
Venue
Proceedings of the National Academy of Sciences
Published
2010-04-30
Volume
107
Issue
20
Pages
9352-9357
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2069812362
Cited by
530
References
30
Citations by year
2026: 20 · 2025: 28 · 2024: 34 · 2023: 30 · 2022: 46 · 2021: 41 · 2020: 44 · 2019: 39 · 2018: 39 · 2017: 34 · 2016: 30 · 2015: 32 · 2014: 32 · 2013: 22 · 2012: 21
FWCI
16.74
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • University of Alberta
  • Science Foundation Ireland
  • Fondation pour la Recherche Médicale
  • Alberta Heritage Foundation for Medical Research
  • Natural Sciences and Engineering Research Council of Canada
Topics
  • Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
  • Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
Keywords
bacteriocins, Clostridium difficile, Clostridium difficile-associated disease, Bacillus thuringiensis, post-translational modification, ribotype 027, ribosome-inactivating proteins, targeted antimicrobial therapy, commensal bacteria
MeSH terms
Amino Acid Sequence, Anti-Bacterial Agents, Bacillus thuringiensis, Bacteriocins, Feces, Humans, Molecular Sequence Data, Protein Processing, Post-Translational, S-Adenosylmethionine, Clostridioides difficile, Nuclear Magnetic Resonance, Biomolecular, Sequence Analysis, Protein, Tandem Mass Spectrometry

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. https://app.cochat.ai/papers/10.1073/pnas.0913554107
The paper
Rea, M. C., Sit, C. S., Clayton, E., O'Connor, P. M., Whittal, R. M., Zheng, J., Vederas, J. C., Ross, R. P., & Hill, C. (2010). Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0913554107

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.